BRCA1 and breast carcinoma: While the presence of a single copy of the p.Ala91Val allele is unlikely to significantly impact cancer risk, it may compromise the antitumor immune response, potentially contributing to the earlier development of certain solid tumors that are known to be controlled by the immune system, such as BRCA1-driven breast carcinomas.